According to American Cancer Society, the percentage of Americans developing liver cancer has been rising slowly for several decades, with the estimated primary liver cancer and intrahepatic bile duct cancer in the United States for 2015 are:
- About 35,660 new cases (25,510 in men and 10,150 in women) will be diagnosed.
- About 24,550 people (17,030 men and 7,520 women) will die of these cancers.
We look into the medical study, clinical results, expert interviews, and AHCC supplement user reviews on the use of AHCC as complementary and alternative medicine (CAM) in liver cancer treatment:
Overview of AHCC And Liver Cancer, Liver Health.
AHCC expert and internationally recognized expert on integrative medicine, Dr Fred Pescatore, M.D., M.P.H. gives an overview about AHCC and liver cancer / health in video below.
AHCC Liver Cancer Research #1: Clinical Study, Results.
Source:
Thammasat University Rangsit Campus, Patumthani, Thailand.
Topic:
Prognostic improvement of patients with advanced liver cancer after AHCC treatment
Abstract:
A prospective cohort study was performed with 44 patients with histologically confirmed liver cancer. Survival time, quality of life, clinical and immunological parameters related to liver function, cellular immunity, and patient status were determined. Of the 44 patients, 34 and 10 received AHCC and placebo (control) orally, respectively.
Results / Conclusion:
- Patients in the AHCC treated-group had a significantly prolonged survival when compared to the control group.
- After 3 months of AHCC treatment, patients showed significantly improved quality of life in terms of mental stability, general physical health status, and ability to have normal activities.
- This study suggests that AHCC intake could prolong the survival and improve the prognosis of patients with advanced liver cancer and delay the gradual decline of their physiological status.
AHCC Liver Cancer Research #2: Clinical Study, Dosage, Results.
Source:
Kansai Medical University, Osaka, Japan.
Topic:
Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort study
Abstract:
A clinical study was performed on 269 patients who underwent resection of a liver tumor. Time to treatment failure (disease recurrence or death) and ten parameters related to liver function after surgery were examined.
AHCC Dosage:
3.0g/day
Results / Conclusion:
- 39 out of 113 patients who received AHCC suffered a recurrence of their cancer (34.5%), while 72 out 109 patients in the control group did (66%) — nearly twice as many.
- Survival rates in the AHCC group were significantly better than those in the control group, with 23 (20.4%) patients had died in the AHCC group by the end of the follow-up period, whereas 51 (46.8%) had died in the control group at the end of the follow-up period.
- The use of AHCC showed no side effects.
- AHCC intake can improve the prognosis of postoperative liver cancer patients.
AHCC Liver Cancer Research #3: Clinical Study, Results.
Source:
Asian Pacific Journal Of Allergy And Immunology (2006)
Topic:
Prognostic improvement of patients with advanced liver cancer after AHCC treatment
Results / Conclusion:
- Based on preliminary results on 23 patients, all 10 (100%) patients in the control group passed away within 3.5 months, whereas 8 out of 13 AHCC-treated patients (61.5%) patients in the AHCC group were still alive after that period.
Best AHCC Supplement Brands Overview
| Brand | ImmunoKinoko | Kinoko Platinum | Kinoko Gold AHCC | NOW Foods AHCC |
| Product Image |  |  |  |  |
| Manufacturer | Quality of Life | Quality of Life | Quality of Life | NOW Foods |
| Learn More |  | | | |